Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Sell
35
TAK Quote, Financials, Valuation and Earnings
Last price:
$13.10
Seasonality move
:
6.06%
Day range:
$13.02 - $13.19
52-week range:
$12.58 - $15.08
Dividend yield:
4.72%
P/E ratio:
21.67x
P/S ratio:
1.38x
P/B ratio:
0.86x
Volume:
1.8M
Avg. volume:
1.8M
1-year change:
-4.31%
Market cap:
$41.5B
Revenue:
$29.5B
EPS (TTM):
$0.60
| Period Ending | 2020-03-31 | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $30.3B | $30.2B | $31.8B | $29.8B | $29.5B | |
| Revenue Growth (YoY) | 60.07% | -0.38% | 5.39% | -6.18% | -0.93% | |
| Cost of Revenues | $10B | $9.4B | $9.9B | $9.2B | $9.9B | |
| Gross Profit | $20.3B | $20.8B | $21.9B | $20.6B | $19.7B | |
| Gross Profit Margin | 66.89% | 68.91% | 68.99% | 69.11% | 66.54% | |
| R&D Expenses | $4.5B | $4.3B | $4.7B | $4.7B | $5.1B | |
| Selling, General & Admin | $8.9B | $8.3B | $7.9B | $7.4B | $7.3B | |
| Other Inc / (Exp) | -$1.8B | $819.1M | -$1.1B | -$417.8M | -$884.9M | |
| Operating Expenses | $17.6B | $16.8B | $17.1B | $16.5B | $17.4B | |
| Operating Income | $2.6B | $3.9B | $4.9B | $4.1B | $2.2B | |
| Net Interest Expenses | $1.3B | $1.3B | $1.1B | $913.7M | $973.4M | |
| EBT. Incl. Unusual Items | -$559M | $3.5B | $2.7B | $2.8B | $365.8M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$966.5M | -$93.7M | $645M | $429.9M | -$633.4M | |
| Net Income to Company | $407.5M | $3.5B | $2.1B | $2.3B | $999.3M | |
| Minority Interest in Earnings | -$450.8K | -$1.6M | -$953.1K | -$155.5K | -$900.9K | |
| Net Income to Common Excl Extra Items | $407.1M | $3.5B | $2B | $2.3B | $998.4M | |
| Basic EPS (Cont. Ops) | $0.13 | $1.14 | $0.66 | $0.76 | $0.32 | |
| Diluted EPS (Cont. Ops) | $0.13 | $1.13 | $0.65 | $0.75 | $0.32 | |
| Weighted Average Basic Share | $3.1B | $3.1B | $3.1B | $3.1B | $3.1B | |
| Weighted Average Diluted Share | $3.1B | $3.1B | $3.2B | $3.1B | $3.2B | |
| EBITDA | $6.2B | $10B | $9B | $8.6B | $6.2B | |
| EBIT | $812M | $4.7B | $3.8B | $3.6B | $1.2B | |
| Revenue (Reported) | $30.3B | $30.2B | $31.8B | $29.8B | $29.5B | |
| Operating Income (Reported) | $2.6B | $3.9B | $4.9B | $4.1B | $2.2B | |
| Operating Income (Adjusted) | $812M | $4.7B | $3.8B | $3.6B | $1.2B | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $7.4B | $7.7B | $7.3B | $7.2B | $7.9B | |
| Revenue Growth (YoY) | -1.69% | 3.25% | -5.47% | -0.47% | 9.64% | |
| Cost of Revenues | $2.4B | $2.5B | $2.2B | $2.4B | $2.7B | |
| Gross Profit | $5.1B | $5.2B | $5B | $4.8B | $5.3B | |
| Gross Profit Margin | 68.36% | 67.35% | 69.53% | 67.06% | 66.47% | |
| R&D Expenses | $1.1B | $1.2B | $1.1B | $1.3B | $1.2B | |
| Selling, General & Admin | $2B | $1.9B | $1.8B | $1.8B | $1.8B | |
| Other Inc / (Exp) | $7.8M | -$28.8M | -$6.3M | $14M | -$605.4M | |
| Operating Expenses | $4.6B | $4.3B | $4.3B | $5.2B | $3.4B | |
| Operating Income | $455.1M | $885.2M | $756M | -$341.6M | $1.8B | |
| Net Interest Expenses | $507.5M | $298.1M | $282.5M | $336.9M | $433.2M | |
| EBT. Incl. Unusual Items | -$44.6M | $558.3M | $467.3M | -$664.5M | $803.7M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$82.9M | $140.4M | $20.4M | -$332.4M | $183.6M | |
| Net Income to Company | $49M | $410.9M | $396.6M | -$364.7M | $650.4M | |
| Minority Interest in Earnings | -$310.9K | -$281.6K | $72.4K | -$408.5K | -$410.7K | |
| Net Income to Common Excl Extra Items | $38M | $417.6M | $446.9M | -$332.5M | $619.7M | |
| Basic EPS (Cont. Ops) | $0.01 | $0.13 | $0.14 | -$0.11 | $0.20 | |
| Diluted EPS (Cont. Ops) | $0.01 | $0.13 | $0.14 | -$0.11 | $0.19 | |
| Weighted Average Basic Share | $3.1B | $3.1B | $3.1B | $3.1B | $3.2B | |
| Weighted Average Diluted Share | $3.1B | $3.2B | $3.1B | $3.1B | $3.2B | |
| EBITDA | $1.9B | $2.2B | $2.1B | $1.4B | $2.6B | |
| EBIT | $557.3M | $918.7M | $856.7M | -$262.8M | $1.3B | |
| Revenue (Reported) | $7.4B | $7.7B | $7.3B | $7.2B | $7.9B | |
| Operating Income (Reported) | $455.1M | $885.2M | $756M | -$341.6M | $1.8B | |
| Operating Income (Adjusted) | $557.3M | $918.7M | $856.7M | -$262.8M | $1.3B | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $29.9B | $31.6B | $30.2B | $30B | $30.3B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $9.4B | $9.5B | $9.6B | $9.4B | $10.3B | |
| Gross Profit | $20.5B | $22.1B | $20.6B | $20.5B | $20B | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $4.5B | $4.5B | $4.6B | $4.9B | $4.9B | |
| Selling, General & Admin | $8.5B | $8.3B | $7.5B | $7.3B | $7.3B | |
| Other Inc / (Exp) | -$2B | $872.3M | -$1B | -$404.9M | -$356.9M | |
| Operating Expenses | $16.8B | $17B | $16.9B | $17.4B | $16.8B | |
| Operating Income | $3.6B | $5.1B | $3.7B | $3.1B | $3.1B | |
| Net Interest Expenses | $1.4B | $1.1B | $811.8M | $1.2B | $1B | |
| EBT. Incl. Unusual Items | $322.5M | $4.9B | $1.8B | $1.4B | $1.8B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$201.8M | $459.8M | $168.9M | $42.1M | -$152.9M | |
| Net Income to Company | $525.7M | $4.4B | $1.6B | $1.4B | $2B | |
| Minority Interest in Earnings | $44.7K | -$1.9M | -$283.9K | -$659.8K | -$1.1M | |
| Net Income to Common Excl Extra Items | $524.3M | $4.4B | $1.7B | $1.4B | $1.9B | |
| Basic EPS (Cont. Ops) | $0.17 | $1.41 | $0.54 | $0.45 | $0.61 | |
| Diluted EPS (Cont. Ops) | $0.17 | $1.40 | $0.53 | $0.44 | $0.60 | |
| Weighted Average Basic Share | -- | -- | -- | -- | -- | |
| Weighted Average Diluted Share | -- | -- | -- | -- | -- | |
| EBITDA | $7.3B | $11.3B | $7.9B | $8.2B | $8.2B | |
| EBIT | $2B | $6.1B | $2.9B | $2.8B | $2.7B | |
| Revenue (Reported) | $29.9B | $31.6B | $30.2B | $30B | $30.3B | |
| Operating Income (Reported) | $3.6B | $5.1B | $3.7B | $3.1B | $3.1B | |
| Operating Income (Adjusted) | $2B | $6.1B | $2.9B | $2.8B | $2.7B | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $14.9B | $16.4B | $14.8B | $14.9B | $15.7B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $4.6B | $4.7B | $4.5B | $4.7B | $5.1B | |
| Gross Profit | $10.3B | $11.6B | $10.3B | $10.2B | $10.5B | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $2.1B | $2.3B | $2.2B | $2.5B | $2.3B | |
| Selling, General & Admin | $3.9B | $3.9B | $3.6B | $3.6B | $3.5B | |
| Other Inc / (Exp) | -$82.9M | -$32M | -$10.1M | $11M | -$610M | |
| Operating Expenses | $8.3B | $8.5B | $8.4B | $9.3B | $7.6B | |
| Operating Income | $2B | $3.2B | $1.9B | $886.9M | $2.9B | |
| Net Interest Expenses | $760.6M | $528.5M | $282.5M | $578.3M | $619.3M | |
| EBT. Incl. Unusual Items | $1.2B | $2.6B | $1.7B | $319.6M | $1.7B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $361M | $919.2M | $409.8M | $146.1K | $448.5M | |
| Net Income to Company | $815.9M | $1.7B | $1.2B | $286.9M | $1.3B | |
| Minority Interest in Earnings | -$385.3K | -$674.5K | $18.4K | -$488.6K | -$737.8K | |
| Net Income to Common Excl Extra Items | $804.8M | $1.7B | $1.3B | $319M | $1.2B | |
| Basic EPS (Cont. Ops) | $0.26 | $0.53 | $0.41 | $0.10 | $0.39 | |
| Diluted EPS (Cont. Ops) | $0.26 | $0.53 | $0.40 | $0.10 | $0.38 | |
| Weighted Average Basic Share | $6.2B | $6.2B | $6.2B | $6.2B | $6.3B | |
| Weighted Average Diluted Share | $6.3B | $6.3B | $6.2B | $6.3B | $6.4B | |
| EBITDA | $4.8B | $6.2B | $4.9B | $4.1B | $5.1B | |
| EBIT | $2.2B | $3.6B | $2.5B | $1.2B | $2.5B | |
| Revenue (Reported) | $14.9B | $16.4B | $14.8B | $14.9B | $15.7B | |
| Operating Income (Reported) | $2B | $3.2B | $1.9B | $886.9M | $2.9B | |
| Operating Income (Adjusted) | $2.2B | $3.6B | $2.5B | $1.2B | $2.5B | |
| Period Ending | 2020-03-31 | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $5.9B | $8.8B | $7B | $4B | $3B | |
| Short Term Investments | $146.4M | $331.8M | $207.3M | $151.4M | $99.7M | |
| Accounts Receivable, Net | $6.6B | $7.1B | $5.8B | $5.1B | $4.7B | |
| Inventory | $7B | $6.8B | $7B | $7.4B | $8B | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $1.1B | $1.1B | $1.2B | $1.2B | $1.1B | |
| Total Current Assets | $22.8B | $24.6B | $21.2B | $18B | $16.9B | |
| Property Plant And Equipment | $12.8B | $13.2B | $13B | $12.7B | $13.1B | |
| Long-Term Investments | $3.4B | $3.2B | $2.7B | $2.8B | $2.8B | |
| Goodwill | $37.1B | $36.6B | $36.1B | $36B | $35.7B | |
| Other Intangibles | $38.6B | $35.4B | $31.3B | $32B | $28.2B | |
| Other Long-Term Assets | $960.9M | $909.6M | $676.8M | $475.3M | $338.4M | |
| Total Assets | $118.6B | $117B | $108B | $104.8B | $99.8B | |
| Accounts Payable | $2B | $2.1B | $2.4B | $2.3B | $2.1B | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | $5.4B | $200.8M | $1.7B | $2.5B | $2.4B | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | $6.3B | $7.2B | $6.4B | $5.6B | $5B | |
| Total Current Liabilities | $20.1B | $16.1B | $17.6B | $18.6B | $15.3B | |
| Long-Term Debt | $41.7B | $41.8B | $33.9B | $30.3B | $29.6B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $74.9B | $70.1B | $61.4B | $57.1B | $51.8B | |
| Common Stock | $15.4B | $15.1B | $13.7B | $12.6B | $11.1B | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | $43.7B | $46.9B | $46.6B | $47.7B | $48.1B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $37M | $37.5M | $4.1M | $4.1M | $4.9M | |
| Total Equity | $43.7B | $46.9B | $46.6B | $47.7B | $48.1B | |
| Total Liabilities and Equity | $118.6B | $117B | $108B | $104.8B | $99.8B | |
| Cash and Short Terms | $6B | $9.1B | $7.2B | $4.2B | $3.1B | |
| Total Debt | $47.1B | $42B | $35.6B | $32.9B | $32B | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $6B | $5.4B | $5.5B | $2.1B | $6B | |
| Short Term Investments | $144.9M | $230M | $221M | $105.5M | $330.5M | |
| Accounts Receivable, Net | $7.1B | $7.5B | $5.3B | $5.1B | $4.9B | |
| Inventory | $7B | $7B | $6.6B | $7.7B | $8.4B | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $1.1B | $1.2B | $1.1B | $1.2B | $1.1B | |
| Total Current Assets | $24.5B | $21.9B | $19B | $16.5B | $21.4B | |
| Property Plant And Equipment | $12.9B | $13B | $12.2B | $12.7B | $13.2B | |
| Long-Term Investments | $3.3B | $3.1B | $2.9B | $2.8B | $1.9B | |
| Goodwill | $36.5B | $36.4B | $34.6B | $35.5B | $36.1B | |
| Other Intangibles | $36.7B | $33.8B | $29B | $29.5B | $26.4B | |
| Other Long-Term Assets | $948.4M | $842.3M | $558.6M | $399.4M | $595.3M | |
| Total Assets | $117.5B | $112.2B | $101B | $99.6B | $102B | |
| Accounts Payable | $2.6B | $3B | $2.7B | $2.8B | $2.9B | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | $2.6B | $1.9B | $3.9B | $1.8B | $4.4B | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | $5.3B | $6.8B | $5.3B | $5.9B | $4.9B | |
| Total Current Liabilities | $16.2B | $17.1B | $16.6B | $15.8B | $16.7B | |
| Long-Term Debt | $43.8B | $35.9B | $28.9B | $29.5B | $31B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $73.3B | $64.6B | $54.5B | $52.2B | $53.6B | |
| Common Stock | $15.8B | $15B | $11.6B | $11.2B | $11.9B | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $38.8M | $3.8M | $3.9M | $4.5M | $5.9M | |
| Total Equity | $44.2B | $47.6B | $46.5B | $47.3B | $48.5B | |
| Total Liabilities and Equity | $117.5B | $112.2B | $101B | $99.6B | $102B | |
| Cash and Short Terms | $6.1B | $5.7B | $5.7B | $2.2B | $6.3B | |
| Total Debt | $46.4B | $37.8B | $32.8B | $31.3B | $35.4B | |
| Period Ending | 2020-03-31 | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $407.5M | $3.5B | $2.1B | $2.3B | $999.3M | |
| Depreciation & Amoritzation | $5.4B | $5.3B | $5.2B | $4.9B | $5B | |
| Stock-Based Compensation | $267.9M | $355.3M | $386.4M | $449.3M | $491.1M | |
| Change in Accounts Receivable | -$320.4M | -$87.9M | $1.1B | $556.4M | $104.7M | |
| Change in Inventories | $1.3B | $245.1M | -$411.1M | -$586.2M | -$802.1M | |
| Cash From Operations | $6.2B | $9.5B | $10B | $7.2B | $5B | |
| Capital Expenditures | $2B | $2.2B | $1.7B | $4.7B | $3.3B | |
| Cash Acquisitions | $4.2B | $5B | -$191.3M | $58.9M | $138.3M | |
| Cash From Investing | $2.7B | $3.7B | -$1.8B | -$4.5B | -$3.2B | |
| Dividends Paid (Ex Special Dividend) | -$2.6B | -$2.7B | -$2.5B | -$2.1B | -$2B | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $4.6B | $11.1B | $2.2B | $555.4M | $693M | |
| Long-Term Debt Repaid | -$10B | -$16B | -$7.6B | -$3B | -$2.6B | |
| Repurchase of Common Stock | -$34.4M | -$20.2M | -$690.6M | -$199.4M | -$16.1M | |
| Other Financing Activities | -$51.5M | -$330.2M | -$3.4M | -$68M | $235.3M | |
| Cash From Financing | -$9.2B | -$10.3B | -$9.5B | -$5.3B | -$2.5B | |
| Beginning Cash (CF) | $6.5B | $6B | $8.6B | $6.3B | $3.7B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$398.8M | $3B | -$1.3B | -$2.5B | -$706.4M | |
| Ending Cash (CF) | $5.9B | $9.1B | $7.6B | $4B | $3.2B | |
| Levered Free Cash Flow | $4.2B | $7.3B | $8.3B | $2.5B | $1.6B | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $49M | $410.9M | $396.6M | -$364.7M | $650.4M | |
| Depreciation & Amoritzation | $1.3B | $1.3B | $1.1B | $1.2B | $1.4B | |
| Stock-Based Compensation | $77.2M | $112.5M | $117.5M | $122.7M | $150M | |
| Change in Accounts Receivable | $225.6M | -$119.2M | $95.9M | $152.7M | -$82.7M | |
| Change in Inventories | $68.9M | -$34.9M | -$43.8M | -$331.2M | -$280.2M | |
| Cash From Operations | $2.3B | $2.1B | $1.6B | $1.3B | $1.9B | |
| Capital Expenditures | $386.1M | $393M | $246.9M | $386.7M | $666.2M | |
| Cash Acquisitions | $295.9M | $1.3M | -- | -$184.1K | $37.2M | |
| Cash From Investing | $259.8M | -$295.4M | -$151.6M | -$322.2M | -$555.6M | |
| Dividends Paid (Ex Special Dividend) | -$98.7M | -$80M | -$18.9M | -$15.1M | -$105.8M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $11.1B | -$9.1K | -- | -$36.5M | $3.4B | |
| Long-Term Debt Repaid | -$12.7B | -$1.9B | -$60.2M | -$1B | -$1.7B | |
| Repurchase of Common Stock | -$304.6K | $128.7K | $12.9M | $848.1K | -$597.8K | |
| Other Financing Activities | -$328.2M | -$118.1K | -$180.6K | $384.9M | -$16.7M | |
| Cash From Financing | -$2.1B | -$2.2B | -$272.3M | -$952.7M | -$640.4M | |
| Beginning Cash (CF) | $5.5B | $6B | $5B | $2.3B | $5.2B | |
| Foreign Exchange Rate Adjustment | -$66M | $540.4K | $63.3M | $22.3M | -$275.8M | |
| Additions / Reductions | $446.9M | -$412.1M | $1.1B | $68.4M | $749.7M | |
| Ending Cash (CF) | $5.9B | $5.5B | $5.8B | $2.2B | $5.8B | |
| Levered Free Cash Flow | $2B | $1.7B | $1.3B | $956.6M | $1.3B | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $525.7M | $4.4B | $1.6B | $1.4B | $2B | |
| Depreciation & Amoritzation | $5.3B | $5.2B | $5B | $5B | $5.2B | |
| Stock-Based Compensation | $312.4M | $375.3M | $408.2M | $472.2M | $504.6M | |
| Change in Accounts Receivable | $167.9M | -$574.8M | $1.6B | $93.2M | $221.6M | |
| Change in Inventories | $723.5M | -$10.1M | -$298.5M | -$1B | -$607.3M | |
| Cash From Operations | $6.7B | $9.5B | $8.6B | $7B | $6B | |
| Capital Expenditures | $2.1B | $2.2B | $1.9B | $6B | $2.5B | |
| Cash Acquisitions | $1B | $4.5B | $39.6M | $61.5M | $191.9M | |
| Cash From Investing | -$126.8M | $2.5B | -$1.7B | -$5.9B | -$2.5B | |
| Dividends Paid (Ex Special Dividend) | -$2.6B | -$2.6B | -$2.3B | -$2B | -$2B | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | $12.7M | $2.2B | $1.2B | $6.6B | |
| Long-Term Debt Repaid | -$12.6B | -$7.2B | -$3.7B | -$4.5B | -$2.8B | |
| Repurchase of Common Stock | -$19.8M | -$23.2M | -$862.5M | -$20.6M | -$12.7M | |
| Other Financing Activities | -$351.2M | -- | -$3.6M | $286.2M | $135.7M | |
| Cash From Financing | -$5.6B | -$12.3B | -$5.5B | -$4.7B | $306.8M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $925.2M | -$321.8M | $1.4B | -$3.5B | $3.8B | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $4.6B | $7.2B | $6.7B | $1B | $3.5B | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $815.9M | $1.7B | $1.2B | $286.9M | $1.3B | |
| Depreciation & Amoritzation | $2.6B | $2.6B | $2.4B | $2.5B | $2.6B | |
| Stock-Based Compensation | $170.5M | $190.5M | $212.4M | $235.2M | $248.7M | |
| Change in Accounts Receivable | -$14.5M | -$501.4M | -$42.8M | -$505.9M | -$389M | |
| Change in Inventories | $28.4M | -$226.8M | -$114.2M | -$539.6M | -$344.8M | |
| Cash From Operations | $3.7B | $3.6B | $2.2B | $2B | $3B | |
| Capital Expenditures | $762.2M | $779.4M | $1B | $2.3B | $1.6B | |
| Cash Acquisitions | $295.9M | -$230.9M | -- | $2.5M | $56.1M | |
| Cash From Investing | $265.9M | -$939M | -$882.6M | -$2.3B | -$1.6B | |
| Dividends Paid (Ex Special Dividend) | -$1.3B | -$1.3B | -$1B | -$967.9M | -$991.7M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $11.1B | -- | -- | $692.3M | $6.6B | |
| Long-Term Debt Repaid | -$12.9B | -$4.2B | -$346.7M | -$1.9B | -$2.1B | |
| Repurchase of Common Stock | -$20.1M | -$23.1M | -$194.9M | -$16.1M | -$12.7M | |
| Other Financing Activities | -$329.3M | -$118.1K | -$304K | $353.9M | $254.2M | |
| Cash From Financing | -$3.9B | -$6B | -$1.9B | -$1.4B | $1.4B | |
| Beginning Cash (CF) | $11.4B | $14.8B | $11.5B | $6.2B | $8.1B | |
| Foreign Exchange Rate Adjustment | -$80.8M | $30.9M | $236.9M | $129.9M | -$165.4M | |
| Additions / Reductions | $17.2M | -$3.3B | -$610.1M | -$1.6B | $2.9B | |
| Ending Cash (CF) | $11.4B | $11.5B | $10.8B | $4.5B | $10.9B | |
| Levered Free Cash Flow | $2.9B | $2.9B | $1.2B | -$332.1M | $1.5B | |
Get TAK Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
TAK
Sector
P/E ratio
21.67x
25.86x
PEG ratio
0.60x
0.00x
P/B ratio
0.86x
1.85x
Price / LTM sales
1.38x
1.86x
Growth Metrics
TAK
Sector
Revenue growth
9.64%
7.28%
Earnings growth
-7.63%
1.82%
Revenue (5-year growth)
9.33%
8.73%
Earnings forecast
--
-$0.20
Profitability
TAK
Sector
Profitability FY 2023
$19.7B
$57.1M
Return on invested capital
2.37%
-14.06%
Return on assets
1.91%
-11.77%
Return on equity
4.01%
-14.78%
Earnings Date
Last Earnings Date
Oct
31
Next Earnings Date
Jan
31
Estimated Next Earnings Date
Jan
30
Balance Sheet
TAK
Sector
Total cash
$6.3B
$47M
Short term investments
$99.7M
$45.2M
Total assets
$99.8B
$142.6M
Long term debt
$35.4B
$6.5M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 21
Quantum [QMCO] is up 26.28% over the past day.
Sell
46
NUKK alert for Dec 21
Nukkleus [NUKK] is down 22.94% over the past day.
Sell
1
IIPR alert for Dec 21
Innovative Industrial Properties [IIPR] is down 22.7% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
